Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity - PubMed (original) (raw)

Review

. 2013 Jun 4;17(6):860-872.

doi: 10.1016/j.cmet.2013.05.001.

Affiliations

• PMID: 23747245
• DOI: 10.1016/j.cmet.2013.05.001

Free article

Review

Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity

Marc Y Donath et al. Cell Metab. 2013.

Free article

Abstract

The role of the immune system is to restore functionality in response to stress. Increasing evidence shows that this function is not limited to insults by infection or injury and plays a role in response to overnutrition. Initially, this metabolic activation of the immune system is a physiological response, but it may become deleterious with time. Therefore, therapeutic interventions should aim at modulating the immune system rather than simply damping it. In this article, we describe the physiology and pathology of the immune system during obesity and diabetes with a focus on islet inflammation, the IL-1β pathway, and clinical translation.

Copyright © 2013 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Similar articles

• Macrophages and islet inflammation in type 2 diabetes.
  Eguchi K, Manabe I. Eguchi K, et al. Diabetes Obes Metab. 2013 Sep;15 Suppl 3:152-8. doi: 10.1111/dom.12168. Diabetes Obes Metab. 2013. PMID: 24003932 Review.
• Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
  Park YJ, Warnock GL, Ao Z, Safikhan N, Meloche M, Asadi A, Kieffer TJ, Marzban L. Park YJ, et al. Diabetes Obes Metab. 2017 May;19(5):682-694. doi: 10.1111/dom.12873. Epub 2017 Feb 27. Diabetes Obes Metab. 2017. PMID: 28058779
• Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes.
  Nunemaker CS. Nunemaker CS. J Diabetes Res. 2016;2016:2846570. doi: 10.1155/2016/2846570. Epub 2016 Oct 23. J Diabetes Res. 2016. PMID: 27843953 Free PMC article. Review.
• Insulitis in type 2 diabetes.
  Böni-Schnetzler M, Ehses JA, Faulenbach M, Donath MY. Böni-Schnetzler M, et al. Diabetes Obes Metab. 2008 Nov;10 Suppl 4:201-4. doi: 10.1111/j.1463-1326.2008.00950.x. Diabetes Obes Metab. 2008. PMID: 18834448
• Setting the Stage for Islet Autoimmunity in Type 2 Diabetes: Obesity-Associated Chronic Systemic Inflammation and Endoplasmic Reticulum (ER) Stress.
  Brooks-Worrell BM, Palmer JP. Brooks-Worrell BM, et al. Diabetes Care. 2019 Dec;42(12):2338-2346. doi: 10.2337/dc19-0475. Diabetes Care. 2019. PMID: 31748213 Free PMC article. Review.

Cited by

• Type 1 and Type 2 Diabetes Mellitus: Commonalities, Differences and the Importance of Exercise and Nutrition.
  Krause M, De Vito G. Krause M, et al. Nutrients. 2023 Oct 7;15(19):4279. doi: 10.3390/nu15194279. Nutrients. 2023. PMID: 37836562 Free PMC article.
• Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?
  Westwell-Roper C, Ehses JA. Westwell-Roper C, et al. Diabetologia. 2014 Mar;57(3):447-50. doi: 10.1007/s00125-013-3151-2. Epub 2013 Dec 21. Diabetologia. 2014. PMID: 24362729
• Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice.
  Xue J, Cheng Y, Hao H, Gao J, Yin Y, Yu S, Zou J, Liu J, Zhang Q, Mu Y. Xue J, et al. Stem Cells Int. 2020 Apr 3;2020:4689798. doi: 10.1155/2020/4689798. eCollection 2020. Stem Cells Int. 2020. PMID: 32322278 Free PMC article.
• Lipoxins reduce obesity-induced adipose tissue inflammation in 3D-cultured human adipocytes and explant cultures.
  Soták M, Rajan MR, Clark M, Harms M, Rani A, Kraft JD, Tandio D, Shen T, Borkowski K, Fiehn O, Newman JW, Quiding-Järbrink M, Biörserud C, Apelgren P, Staalesen T, Hagberg CE, Boucher J, Wallenius V, Lange S, Börgeson E. Soták M, et al. iScience. 2022 Jun 11;25(7):104602. doi: 10.1016/j.isci.2022.104602. eCollection 2022 Jul 15. iScience. 2022. PMID: 35789845 Free PMC article.
• Effects of IL-1β-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms.
  Palmér R, Nyman E, Penney M, Marley A, Cedersund G, Agoram B. Palmér R, et al. CPT Pharmacometrics Syst Pharmacol. 2014 Jun 11;3(6):e118. doi: 10.1038/psp.2014.16. CPT Pharmacometrics Syst Pharmacol. 2014. PMID: 24918743 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)